Tirzepatide (Zepbound | Mounjaro*) A dual GIP/GLP-1 receptor agonist
These protective benefits have been observed in the GI tract, liver, cardiovascular system, and brain [20, 36]
Mounjaro Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes mellitus.It is not known if Mounjaro can be used in people who have had pancreatitis
In particular, several studies suggested that some anti-diabetic drugs could be of potential interest because of their anti-cancer effects demonstrated both in vitro and in vivo on TC
Love Employee stock.adobe.com News Study finds faster regain than ending diet programmes GLP-1 discontinuation: weight-loss drugs work until you stop Research sounds a cautionary note for short-term use without a more comprehensive approach to weight management People tend to regain weight rapidly after stopping weight-loss drugs - and faster than after ending behavioural weight loss programmes - according to a new systematic review and meta-analysis from researchers in Oxford's Nuffield Department of Primary Care Health Sciences, published in The BMJ
Byetta is given as an injection under the skin